Kentaro Miyake

3.0k total citations
113 papers, 1.9k citations indexed

About

Kentaro Miyake is a scholar working on Biotechnology, Oncology and Biomedical Engineering. According to data from OpenAlex, Kentaro Miyake has authored 113 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Biotechnology, 45 papers in Oncology and 45 papers in Biomedical Engineering. Recurrent topics in Kentaro Miyake's work include Cancer Research and Treatments (78 papers), Nanoplatforms for cancer theranostics (43 papers) and Virus-based gene therapy research (42 papers). Kentaro Miyake is often cited by papers focused on Cancer Research and Treatments (78 papers), Nanoplatforms for cancer theranostics (43 papers) and Virus-based gene therapy research (42 papers). Kentaro Miyake collaborates with scholars based in Japan, United States and South Korea. Kentaro Miyake's co-authors include Robert M. Hoffman, Kentaro Igarashi, Michael Bouvet, Tasuku Kiyuna, Kei Kawaguchi, Takashi Murakami, Shree Ram Singh, Takashi Higuchi, Qinghong Han and Itaru Endo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

In The Last Decade

Kentaro Miyake

105 papers receiving 1.9k citations

Peers

Countries citing papers authored by Kentaro Miyake

Since Specialization

Citations

This map shows the geographic impact of Kentaro Miyake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kentaro Miyake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kentaro Miyake more than expected).

Fields of papers citing papers by Kentaro Miyake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kentaro Miyake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kentaro Miyake. The network helps show where Kentaro Miyake may publish in the future.

Co-authorship network of co-authors of Kentaro Miyake

This figure shows the co-authorship network connecting the top 25 collaborators of Kentaro Miyake. A scholar is included among the top collaborators of Kentaro Miyake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kentaro Miyake. Kentaro Miyake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy of Conversion Surgery for Initially Unresectable Biliary Tract Cancer That Has Responded to Down-Staging Chemotherapy 2025 ·Cancers ·Takashi Murakami, (unknown), Yasuhiro Yabushita, Yuki Homma, Yu Sawada, Kentaro Miyake, (unknown), Kazuhisa Takeda, Shin Maeda, Shoji Yamanaka, (unknown)	1
2	Methionine restriction inhibits pancreatic cancer proliferation while suppressing JAK2/STAT3 pathway 2024 ·Pancreatology ·(unknown), Kentaro Miyake, Jun Yamamoto, Kota Sahara, Tomoko Akiyama, Yayoi Kimura, Itaru Endo	1
3	Colon-cancer liver metastasis is effectively targeted by recombinant methioninase (rMETase) in an orthotopic mouse model 2023 ·Tissue and Cell ·Kentaro Miyake, Qinghong Han, Takashi Murakami, Tasuku Kiyuna, Kei Kawaguchi, Kentaro Igarashi, Thinzar M. Lwin, (unknown), Jun Yamamoto, Michael Bouvet, (unknown), Robert M. Hoffman	3
4	Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma 2022 ·Annals of Surgical Oncology ·Ryusei Matsuyama, Rintaro Mori, (unknown), Yuki Homma, (unknown), (unknown), Takashi Murakami, Yu Sawada, Kentaro Miyake, Yasuhiro Shimizu, Takafumi Kumamoto, Itaru Endo	13
5	Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse model 2020 ·Cancer Letters ·Jun Yamamoto, Kentaro Miyake, Qinghong Han, Yuying Tan, Sachiko Inubushi, Norihiko Sugisawa, Takashi Higuchi, Yoshihiko Tashiro, Hiroto Nishino, Yuki Homma, Ryusei Matsuyama, Sant P. Chawla, Michael Bouvet, Shree Ram Singh, Itaru Endo, Robert M. Hoffman	32
6	Trabectedin and irinotecan combination regresses a cisplatinum-resistant osteosarcoma in a patient-derived orthotopic xenograft nude-mouse model 2019 ·Biochemical and Biophysical Research Communications ·Takashi Higuchi, Kentaro Miyake, Hiromichi Oshiro, Norihiko Sugisawa, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Sant P. Chawla, Michael Bouvet, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman	35
7	A patient-derived orthotopic xenograft (PDOX) nude-mouse model precisely identifies effective and ineffective therapies for recurrent leiomyosarcoma 2019 ·Pharmacological Research ·Zhiying Zhang, Kaiwen Hu, Tasuku Kiyuna, Kentaro Miyake, Kei Kawaguchi, Kentaro Igarashi, Scott D. Nelson, Yunfeng Li, Shree Ram Singh, Robert M. Hoffman	18
8	Combination of oral recombinant methioninase and decitabine arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma patient-derived orthotopic xenograft mouse model 2019 ·Biochemical and Biophysical Research Communications ·Takashi Higuchi, Qinghong Han, Kentaro Miyake, Hiromichi Oshiro, Norihiko Sugisawa, Yuying Tan, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Michael Bouvet, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman	26
9	Olaratumab combined with doxorubicin and ifosfamide overcomes individual doxorubicin and olaratumab resistance of an undifferentiated soft-tissue sarcoma in a PDOX mouse model 2019 ·Cancer Letters ·Takashi Higuchi, Kentaro Miyake, Norihiko Sugisawa, Hiromichi Oshiro, Zhiying Zhang, Sahar Razmjooei, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Michael Bouvet, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman	12
10	Induction of Metastasis by Low-dose Gemcitabine in a Pancreatic Cancer Orthotopic Mouse Model: An Opposite Effect of Chemotherapy 2019 ·Anticancer Research ·Norihiko Sugisawa, Kentaro Miyake, Takashi Higuchi, Hiromichi Oshiro, Zhiying Zhang, Jun Ho Park, Kei Kawaguchi, Sant P. Chawla, Michael Bouvet, Shree Ram Singh, Michiaki Unno, Robert M. Hoffman	8
11	Regorafenib regressed a doxorubicin-resistant Ewing’s sarcoma in a patient-derived orthotopic xenograft (PDOX) nude mouse model 2019 ·Cancer Chemotherapy and Pharmacology ·Kentaro Miyake, Tasuku Kiyuna, Kei Kawaguchi, Takashi Higuchi, Hiromichi Oshiro, Zhiying Zhang, Sintawat Wangsiricharoen, Sahar Razmjooei, Yunfeng Li, Scott D. Nelson, Takashi Murakami, Yukihiko Hiroshima, Ryusei Matsuyama, Michael Bouvet, Sant P. Chawla, Shree Ram Singh, Itaru Endo, Robert M. Hoffman	18
12	Patient-derived orthotopic xenograft models of sarcoma 2019 ·Cancer Letters ·Kentaro Igarashi, Kei Kawaguchi, Takashi Murakami, Kentaro Miyake, Tasuku Kiyuna, Masuyo Miyake, Yukihiko Hiroshima, Takashi Higuchi, Hiromichi Oshiro, Scott D. Nelson, Sarah Dry, Yunfeng Li, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman	19
13	Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model 2019 ·Archives of Gynecology and Obstetrics ·Kentaro Miyake, Takuya Murata, Takashi Murakami, Ming Zhao, Tasuku Kiyuna, Kei Kawaguchi, Kentaro Igarashi, Masuyo Miyake, Thinzar M. Lwin, (unknown), (unknown), Takashi Kikuchi, Michael Bouvet, Koichiro Shimoya, Shree Ram Singh, Itaru Endo, Robert M. Hoffman	16
14	Gemcitabine combined with docetaxel precisely regressed a recurrent leiomyosarcoma peritoneal metastasis in a patient-derived orthotopic xenograft (PDOX) model 2019 ·Biochemical and Biophysical Research Communications ·Kentaro Miyake, Tasuku Kiyuna, Masuyo Miyake, Kei Kawaguchi, Zhiying Zhang, Sintawat Wangsiricharoen, Sahar Razmjooei, Hiromichi Oshiro, Takashi Higuchi, Yunfeng Li, Scott D. Nelson, Takashi Murakami, Yukihiko Hiroshima, Takafumi Kumamoto, Ryusei Matsuyama, Michael Bouvet, Shree Ram Singh, Sant P. Chawla, Itaru Endo, Robert M. Hoffman	13
15	The combination of olaratumab with gemcitabine and docetaxel arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft mouse model 2019 ·Cancer Chemotherapy and Pharmacology ·Takashi Higuchi, Kentaro Miyake, Norihiko Sugisawa, Hiromichi Oshiro, Zhiying Zhang, Sahar Razmjooei, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Michael Bouvet, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman	7
16	The combination of gemcitabine and nab-paclitaxel as a novel effective treatment strategy for undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model 2019 ·Biomedicine & Pharmacotherapy ·Takashi Higuchi, Kei Kawaguchi, Kentaro Miyake, Hiromichi Oshiro, Zhiying Zhang, Sahar Razmjooei, Sintawat Wangsiricharoen, Kentaro Igarashi, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Scott D. Nelson, Sarah Dry, Yunfeng Li, Sant P. Chawla, Frederick C. Eilber, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman	11
17	Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer 2018 ·Cancer Letters ·Kei Kawaguchi, Kentaro Miyake, Qinghong Han, Shukuan Li, Yuying Tan, Kentaro Igarashi, Tasuku Kiyuna, Masuyo Miyake, Takashi Higuchi, Hiromichi Oshiro, Zhiying Zhang, Sahar Razmjooei, Sintawat Wangsiricharoen, Michael Bouvet, Shree Ram Singh, Michiaki Unno, Robert M. Hoffman	71
18	Tumor-targeting Salmonella typhimurium A1-R is a highly effective general therapeutic for undifferentiated soft tissue sarcoma patient-derived orthotopic xenograft nude-mouse models 2018 ·Biochemical and Biophysical Research Communications ·Kentaro Igarashi, Kei Kawaguchi, Tasuku Kiyuna, Kentaro Miyake, Masuyo Miyake, Arun S. Singh, Mark A. Eckardt, Scott D. Nelson, Tara A. Russell, Sarah Dry, Yunfeng Li, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Hiroyuki Tsuchiya, Shree Ram Singh, Fritz C. Eilber, Robert M. Hoffman	26
19	Patterns of sensitivity to a panel of drugs are highly individualised for undifferentiated/unclassified soft tissue sarcoma (USTS) in patient-derived orthotopic xenograft (PDOX) nude-mouse models 2018 ·Journal of drug targeting ·Kei Kawaguchi, Kentaro Igarashi, Kentaro Miyake, Tasuku Kiyuna, Masuyo Miyake, Arun S. Singh, Bartosz Chmielowski, Scott D. Nelson, Tara A. Russell, Sarah Dry, Yunfeng Li, Michiaki Unno, Shree Ram Singh, Fritz C. Eilber, Robert M. Hoffman	15
20	Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model 2018 ·BMC Cancer ·Tasuku Kiyuna, Yasunori Tome, Takashi Murakami, Kei Kawaguchi, Kentaro Igarashi, Kentaro Miyake, (unknown), Yunfeng Li, Scott D. Nelson, Sarah Dry, Arun S. Singh, Tara A. Russell, Irmina A. Elliott, Shree Ram Singh, Fuminori Kanaya, Fritz C. Eilber, Robert M. Hoffman	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact